Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
AxoGen, Inc.
AXGN · SEC Filings
website
622
AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices ...
Price
50.64
Market Cap
2.55 B
Float
49.93 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about AXGN
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
AxoGen, Inc.
AXGN · SEC Filings
49.93 M
Float
50.64
Price
2.55 B
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 29, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 28, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 24, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 5, 2025
News
TYPE
HEADLINE
FILED AT
8-K
NEW
Axogen Corporation Investor Presentation on Prostate Nerve Reconstruction and Market Launch
Nov 9, 2026
8-K
Axogen Reports Third Quarter 2026 Financial Results and Raises Full Year Revenue Guidance
Oct 28, 2026
8-K
Axogen Completes Acquisition of BioCircuit Technologies
Oct 1, 2026
8-K/A
Acquisition of BioCircuit Technologies Aims to Enhance Nerve Repair Capabilities and Expand Market Reach
Sep 10, 2026
8-K
Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies for $200 Million
Sep 10, 2026
8-K
Axogen, Inc. Reports Second Quarter 2026 Financial Results and Raises Full Year Revenue Guidance
Jul 29, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B5
REGISTERED OFFERING
Sep 10, 2026
424B5
REGISTERED OFFERING
Jan 23, 2026
424B5
PENDING FIXED PRICE OFFERING | Offering amount: $85,000,000 | Bank: Wells Fargo Securities, Mizuho, Canaccord Genuity, Raymond James
Jan 21, 2026
424B3
247,699 Shares-
Jan 8, 2021
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]
May 9, 2018
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]
May 7, 2018
Registrations
TYPE
HEADLINE
FILED AT
S-3ASR
January 2026 SHELF
Jan 21, 2026
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 5, 2025
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 9, 2024
S-3/A
SHELF | Offering amount: $100,000,000.00 EFFECTIVE
Mar 29, 2024
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 6, 2024
S-3
SHELF | Offering amount: $100,000,000.00 EFFECTIVE
Mar 6, 2024
Proxies
TYPE
HEADLINE
FILED AT
Ownerships
TYPE
HEADLINE
FILED AT
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
Apr 30, 2024
CORRESP
Form CORRESP - Correspondence
Apr 26, 2024
CORRESP
Form CORRESP - Correspondence
Mar 29, 2024
LETTER
Form UPLOAD - SEC-generated letter
Mar 19, 2024
EFFECT
Form EFFECT - Notice of Effectiveness
Mar 14, 2024
EFFECT
Form EFFECT - Notice of Effectiveness
Apr 8, 2022
